Bullish
C-Scrub antiseptic tops $1.5M, aims for $7.4M across Europe
Cosmos Health reported over $1.5 million in combined annualized sales for its C-Scrub and C-Sept antiseptic brands in the UK and Greece, with gross ma...
Bullish
Cosmos Health reported over $1.5 million in combined annualized sales for its C-Scrub and C-Sept antiseptic brands in the UK and Greece, with gross ma...
Bullish
Cosmos Health Inc. (NASDAQ:COSM) has been granted an additional 180-day extension by Nasdaq to regain compliance with the minimum bid price requiremen...
Cosmos Health (NASDAQ: COSM) has received an additional 180-day extension from Nasdaq, until December 7, 2026, to regain compliance with the $1.00 min...
Bullish
Cosmos Health's CEO, Greg Siokas, issued a letter detailing the company's record growth, strategic advancements, and future outlook. Key highlights in...